Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EDC4 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-07 |
mRNA | ADGRF4 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
mRNA | TMEM265 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-07 |
mRNA | BRD8 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
mRNA | S100A8 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | SLC36A2 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | LIX1L | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-07 |
mRNA | ALDH1A3 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
mRNA | PMEPA1 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
mRNA | GALNT3 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-07 |